Return to study ST000444 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

Select	Metabolite Name	Metabolite Id	Refmet Name	Ret. Index	Quant. m/z	Analysis Display
	4-Hydroxypropofol	ME150253	4-Hydroxypropofol	-	-	Reversed phase POSITIVE ION MODE
	Bepridil	ME150250	Bepridil	-	-	Reversed phase POSITIVE ION MODE
	Cinnarizine	ME150263	Cinnarizine	-	-	Reversed phase POSITIVE ION MODE
	Clidinium	ME150261	Clidinium	-	-	Reversed phase POSITIVE ION MODE
	Flunarizine	ME150264	Flunarizine	-	-	Reversed phase POSITIVE ION MODE
	Fluspirilene	ME150267	Fluspirilene	-	-	Reversed phase POSITIVE ION MODE
	Glisoxepide	ME150271	Glisoxepide	-	-	Reversed phase POSITIVE ION MODE
	Mepyramine	ME150248	Mepyramine	-	-	Reversed phase POSITIVE ION MODE
	Nadolol	ME150246	Nadolol	-	-	Reversed phase POSITIVE ION MODE
	Propofol	ME150254	Propofol	-	-	Reversed phase POSITIVE ION MODE
	Terfenadine	ME150266	Terfenadine	-	-	Reversed phase POSITIVE ION MODE
	Verapamil	ME150270	Verapamil	-	-	Reversed phase POSITIVE ION MODE